¾Ï »ý°Ë ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : Á¦Ç°º°, À¯Çüº°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Core Needle Biopsy), By Application (Breast Cancer, Lung Cancer), By Product (Kits & Consumables, Instruments), By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1571426
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,311,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,708,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,502,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾Ï »ý°Ë ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ ¾Ï »ý°Ë ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 516¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2024-2030³â CAGRÀº 8.11%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÐÀÚ ÀÇÇÐÀÇ ¹ßÀüÀ¸·Î ¾ÏÀÇ ºÐÀÚ Æ¯¼º ºÐ¼®À» À§ÇÑ »õ·Î¿î ÀåºñÀÇ °³¹ßÀÌ ¿ëÀÌÇØÁ³½À´Ï´Ù. ±× °á°ú, ¾×ü»ý°ËÀÇ ¼ö¿ë°ú ½ÂÀÎ Áõ°¡´Â Àüü ½ÃÀå ¼ºÀåÀÇ Å« ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¹Àº ½ÅÈï Á¦Á¶¾÷üµéÀÌ ³»½Ã°æ ±â¹Ý ¾Ï »ý°ËÀ» °³¼±ÇÒ ¼ö ÀÖ´Â Àåºñ °³¹ß¿¡ Àü³äÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 3¿ù ½º¿þµ§ÀÇ BiBBInstruments AB´Â EndoDrillÀ̶ó´Â ºê·£µå·Î ¾Ï »ý°Ë ½ÃÀå¿¡¼­ È®°íÇÑ ÀÔÁö¸¦ ±¸ÃàÇß½À´Ï´Ù. ÀÌ È¸»ç´Â ±âÁ¸ »ý°Ë±â±¸¿Í °ü·ÃÇÏ¿© ¾Ï ȯÀÚÀÇ ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´ÜÀ» °¡´ÉÇÏ°Ô ÇÏ´Â »ý°Ë±â±¸¸¦ º¯°æÇß½À´Ï´Ù. ¶ÇÇÑ ÄÚ¾î´Ïµé ¹× ¿¬¼º ³»½Ã°æ »ý°Ë¿¡ ´ëÀÀÇÏ´Â »ý°Ë±â±¸¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½ÅÈï ±¹°¡ ½ÃÀåÀ» °³Ã´Çϰí ÀÖ´Â ±â¾÷Àº ¾Ï »ý°Ë ±â±¸ÀÇ Á¢±Ù¼ºÀ» ³ôÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¾¾çÇÐ ±â¹Ý À¯Àüü µ¥ÀÌÅÍ ºÐ¼® ¹× ¸ÂÃãÇü ÀÇ·á ºÐ¾ß´Â ¾×ü»ý°ËÀÇ µîÀåÀ¸·Î À¯¸®ÇÑ Àü¸ÁÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±ÔÁ¦ ´ç±¹Àº ¾×ü»ý°ËÀÌ °¡Áø Å« ÀáÀç·ÂÀ¸·Î ÀÎÇØ À̵é Á¦Ç°ÀÇ »ó¿ëÈ­¸¦ Àû±ØÀûÀ¸·Î Áö¿øÇϸç ÀÓ»ó ÇöÀå¿¡¼­ÀÇ È°¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾×ü»ý°ËÀº ´Ù¾çÇÑ Ã¼¾×À» ÅëÇØ ¾ÏÀ» ½±°Ô °ËÃâÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ ±â¼úÀÇ ¹ßÀüÀ¸·Î Áø´ÜÀ» À§ÇÑ ¾Ï »ýü ¹°ÁúÀ» ¾ò±â À§ÇÑ ¸Å·ÂÀûÀÎ ºñħ½ÀÀû Á¢±Ù¹ýÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸®Äûµå ¹ÙÀÌ¿À¿É½Ã ºÐ¾ß´Â ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶ ¹× À¯Àüü µ¥ÀÌÅÍ ºÐ¼® °ü·Ã ±â¾÷ÀÇ ´ë±Ô¸ð ÅõÀÚ¿Í Àü·«Àû ³ë·ÂÀ¸·Î ÀÎÇØ ÇâÈÄ ¼ö³â°£ ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Å»ý ±â¾÷Àº QIAGEN Bioinformatics, Fabric Genomics, Agilent Technologies, SOPHiA Genetics¿Í °°Àº ±âÁ¸ ¾÷°è Âü¿© ±â¾÷°ú ÆÄÆ®³Ê½ÊÀ» ¸Î´Â °æÇâÀÌ °­ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °øµ¿ ¿¬±¸ µ¿ÇâÀº Àüü ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Ï »ý°Ë ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ¾Ï »ý°Ë ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¾Ï »ý°Ë ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¾Ï »ý°Ë ½ÃÀå : À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¾Ï »ý°Ë ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ¾Ï »ý°Ë ½ÃÀå : À¯Çü, Á¦Ç°, ¿ëµµ, ¿ëµµº° Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Cancer Biopsy Market Growth & Trends:

The global cancer biopsy market size is expected to reach USD 51.61 billion by 2030, registering a CAGR of 8.11% from 2024 to 2030, according to a new report by Grand View Research, Inc. The advancement in molecular medicine has facilitated the creation of novel devices for the molecular characterization of cancers. As a result, the rising acceptance and approvals of liquid biopsies are anticipated to be significant driving forces behind the overall market growth.

Numerous emerging manufacturers are dedicated to developing instruments that can improve endoscopy-based cancer biopsies. For instance, in March 2023, BiBBInstruments AB, a Swedish company, established a strong presence in the cancer biopsy instruments market under the brand - EndoDrill. The company changed biopsy instruments that allow rapid and precise diagnosis of cancer patients related to existing biopsy instruments. Moreover, it offers biopsy instruments catering to core needles and flexible endoscopic biopsies. Such companies developing in the market are expected to upsurge the accessibility of cancer biopsy instruments.

The field of oncology-based genomic data analysis and personalized medicine is anticipated to witness lucrative prospects with the emergence of liquid biopsies. Regulatory bodies are actively backing the commercialization of these products and promoting their utilization in clinical settings due to the significant potential they offer. Liquid biopsy facilitates cancer detection through various body fluids, and the advancements in this technique have made it an appealing noninvasive approach for obtaining cancer biomaterials for diagnostic purposes.

The liquid biopsies segment is projected to experience rapid expansion in the upcoming years, driven by significant investments and strategic efforts from companies engaged in biopharmaceutical manufacturing and genomic data analysis. Emerging companies are showing a strong inclination towards forming partnerships with established industry participants like QIAGEN Bioinformatics, Fabric Genomics, Agilent Technologies, and SOPHiA Genetics. This collaborative trend is expected to further boost the overall market growth.

Cancer Biopsy Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Cancer Biopsy Market Variables, Trends & Scope

Chapter 4. Cancer Biopsy Market: Product Estimates & Trend Analysis

Chapter 5. Cancer Biopsy Market: Type Estimates & Trend Analysis

Chapter 6. Cancer Biopsy Market: Application Estimates & Trend Analysis

Chapter 7. Cancer Biopsy Market: Regional Estimates & Trend Analysis by Type, Tube Material, Application, and End-use

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â